Oragenics, Inc. (NYSE:OGEN) Buy on Dips

By HEFFX Australia on July 5, 2020   Headline News, Heffx Insights, Investments, Shayne Heffernan, Shayne Heffernan, Stocks, Top Stories, US Stocks  

$OGEN #USA #NYSE #Stocks #MedicalResearch #ShayneHeffernan OragenicsTicker: NYSE:OGENPrice: $0.75Recommendation: BuyTarget Price: $2.50 Business Summary Oragenics, Inc. is a healthcare company. The Company is focused on developing treatments for oral mucositis and novel antibiotics against infectious disease. The Company is focused on developing of the TerraCoV2 immunization product candidate. The Company’s product candidate includes, OG716, as […]